Ivan Fedyunin
Director/Board Member at Melcap Systems Ltd.
Profile
Ivan Fedyunin is currently a Director at BrainQ Technologies Ltd., Melcap Systems Ltd., Broadq Technologies Ltd., Vigorous Solutions Ltd., and Ocular Discovery Ltd.
He previously worked as an Independent Director at Cleveland BioLabs, Inc. from 2018 to 2021, as a Director-Research & Development at Pharmapark LLC from 2014 to 2017, and as the Chief Operating Officer at Promogen-MAT LLC from 2013 to 2017.
Fedyunin received his undergraduate degree from Moscow State University Lomonosov in 2008 and his doctorate from the University of Potsdam in 2012.
Ivan Fedyunin active positions
| Companies | Position | Start |
|---|---|---|
| Melcap Systems Ltd. | Director/Board Member | - |
| Broadq Technologies Ltd. | Director/Board Member | - |
| Ocular Discovery Ltd. | Director/Board Member | - |
| Vigorous Solutions Ltd. | Director/Board Member | - |
BrainQ Technologies Ltd.
 BrainQ Technologies Ltd. Packaged SoftwareTechnology Services BrainQ Technologies Ltd. develops a detection and non-invasive treatment technology to help patients with paralysis move their limbs. The company was founded by Segal Yaron, Drechsler Yotam, and Shohami Emerita Esther on August 14, 2011 and is headquartered in Jerusalem, Israel. | Director/Board Member | - |
Former positions of Ivan Fedyunin
| Companies | Position | End |
|---|---|---|
| STATERA BIOPHARMA, INC. | Director/Board Member | 2021-07-26 |
Pharmapark LLC
 Pharmapark LLC Pharmaceuticals: MajorHealth Technology Part of Bioprocess Holding, Pharmapark LLC is a privately-owned Russian biopharmaceutical company that specializes in the development, manufacture, and commercialization of biosimilar products. The company is based in Moscow, Russian Federation. The company has a successful track record of performing complete biotechnological drug development through commercial production and has marketed five biosimilar products. Pharmapark also has an in-house pipeline of novel formulations and biosimilars focused on value-adding treatments. | Chief Tech/Sci/R&D Officer | 2017-03-31 |
Promogen-MAT LLC
 Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Chief Operating Officer | 2017-03-31 |
Training of Ivan Fedyunin
| Moscow State University Lomonosov | Undergraduate Degree |
| University of Potsdam | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Pharmapark LLC
Pharmapark LLC Pharmaceuticals: MajorHealth Technology Part of Bioprocess Holding, Pharmapark LLC is a privately-owned Russian biopharmaceutical company that specializes in the development, manufacture, and commercialization of biosimilar products. The company is based in Moscow, Russian Federation. The company has a successful track record of performing complete biotechnological drug development through commercial production and has marketed five biosimilar products. Pharmapark also has an in-house pipeline of novel formulations and biosimilars focused on value-adding treatments. | Health Technology |
Promogen-MAT LLC
Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Health Services |
BrainQ Technologies Ltd.
BrainQ Technologies Ltd. Packaged SoftwareTechnology Services BrainQ Technologies Ltd. develops a detection and non-invasive treatment technology to help patients with paralysis move their limbs. The company was founded by Segal Yaron, Drechsler Yotam, and Shohami Emerita Esther on August 14, 2011 and is headquartered in Jerusalem, Israel. | Technology Services |
| Melcap Systems Ltd. | |
| Broadq Technologies Ltd. | |
| Vigorous Solutions Ltd. | |
| Ocular Discovery Ltd. |
- Stock Market
- Insiders
- Ivan Fedyunin
